secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0000950170-24-066552
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics announces annual meeting results; all director nominees elected
--------------------------------------------------------------------------------

- Annual meeting held May 29, 2024; all eight director nominees elected with overwhelming support.
- Nominees: Talat Imran, Mir Imran, Dennis Ausiello, Jean-Luc Butel, Laureen DeBuono, Andrew Farquharson, Malik Nanavaty, Lisa Rometty.
- Ernst & Young ratified as independent auditor for FY2024 with approx. 232M votes for, 16K against.
- Class A and Class B shares voted together; Class B shares have ten votes per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017024066552/0000950170-24-066552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017024066552/rani-20240529.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-066552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer